Skip to main content

Advertisement

Log in

Adjuvant radiotherapy for vulvar cancer with close or positive surgical margins

  • Original Article – Clinical Oncology
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

The survival effect of adjuvant radiotherapy (RT) for vulvar cancer has been poorly investigated.

Patients and methods

We performed a multicentre retrospective register study of 257 patients with primary squamous vulvar cancer. The survival effect of adjuvant RT was investigated in two groups of patients, dependent on surgical margins. The outcome measure was overall survival. All statistical tests were two-sided.

Results

Of the 257 patients investigated, 192 had negative resection margins, while positive and/or close surgical margins were observed in 65 cases. Margin status was associated with unfavourable overall survival. The five-year overall survival was 66.1 and 49.2 % in patients with negative and positive/close resection margins, respectively. Adjuvant RT directed to the vulva was associated with improved survival in patients with positive/close resection margins but not in patients with negative surgical margins. The 5-year overall survival of patients with positive/close surgical margins without RT was 29 %, whereas with RT it increased to 67.6 %. Notably, patients with positive/close surgical margins who received RT of the vulva had a 5-year survival rate similar to the patients with negative margins (67.6 %). Multivariate analysis adjusted for age, stage of disease, tumour grade and lymph node metastases showed that adjuvant RT significantly reduced the mortality risk in patients with positive/close resection margins (HR 0.36, CI 0.14–0.94, p = 0.038). In the group of patients with negative resection margins, the involvement of lymph nodes was the strongest unfavourable prognostic factor.

Conclusions

Adjuvant RT should be used for patients with positive/close surgical margins to improve their outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Busch M, Wagener B, Schaffer M, Duhmke E (2000) Long-term impact of postoperative radiotherapy in carcinoma of the vulva FIGO I/II. Int J Radiat Oncol Biol Phys 48:213–218

    Article  PubMed  CAS  Google Scholar 

  • Chan JK, Sugiyama V, Pham H, Gu M, Rutgers J, Osann K, Cheung MK, Berman ML, Disaia PJ (2007) Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysis. Gynecol Oncol 104:636–641

    Article  PubMed  Google Scholar 

  • de Hullu JA, van der Zee AG (2006) Surgery and radiotherapy in vulvar cancer. Crit Rev Oncol Hematol 60:38–58

    Article  PubMed  Google Scholar 

  • Eggemann H, Ignatov T, Burger E, Kantelhardt EJ, Fettke F, Thomssen C, Costa SD, Ignatov A (2015) Moderate HER2 expression as prognostic factor in hormone receptor positive breast cancer. Endocr Relat Cancer 22:725–733

    Article  PubMed  Google Scholar 

  • Faul CM, Mirmow D, Huang Q, Gerszten K, Day R, Jones MW (1997) Adjuvant radiation for vulvar carcinoma: improved local control. Int J Radiat Oncol Biol Phys 38:381–389

    Article  PubMed  CAS  Google Scholar 

  • Gadducci A, Cionini L, Romanini A, Fanucchi A, Genazzani AR (2006) Old and new perspectives in the management of high-risk, locally advanced or recurrent, and metastatic vulvar cancer. Crit Rev Oncol Hematol 60:227–241

    Article  PubMed  Google Scholar 

  • Heaps JM, Fu YS, Montz FJ, Hacker NF, Berek JS (1990) Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol 38:309–314

    Article  PubMed  CAS  Google Scholar 

  • Ignatov T, Eggemann H, Burger E, Fettke F, Costa SD, Ignatov A (2015) Moderate level of HER2 expression and its prognostic significance in breast cancer with intermediate grade. Breast Cancer Res Treat 151:357–364

    Article  PubMed  CAS  Google Scholar 

  • Judson PL, Habermann EB, Baxter NN, Durham SB, Virnig BA (2006) Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol 107:1018–1022

    Article  PubMed  Google Scholar 

  • Mahner S, Jueckstock J, Hilpert F, Neuser P, Harter P, de Gregorio N, Hasenburg A, Sehouli J, Habermann A, Hillemanns P, Fuerst S, Strauss HG, Baumann K, Thiel F, Mustea A, Meier W, du Bois A, Griebel LF, Woelber L (2015) Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study. J Natl Cancer Inst 107:dju426

    Article  PubMed  PubMed Central  Google Scholar 

  • Pao WM, Perez CA, Kuske RR, Sommers GM, Camel HM, Galakatos AE (1988) Radiation therapy and conservation surgery for primary and recurrent carcinoma of the vulva: report of 40 patients and a review of the literature. Int J Radiat Oncol Biol Phys 14:1123–1132

    Article  PubMed  CAS  Google Scholar 

  • Perez CA, Grigsby PW, Chao C, Galakatos A, Garipagaoglu M, Mutch D, Lockett MA (1998) Irradiation in carcinoma of the vulva: factors affecting outcome. Int J Radiat Oncol Biol Phys 42:335–344

    Article  PubMed  CAS  Google Scholar 

  • Piura B, Masotina A, Murdoch J, Lopes A, Morgan P, Monaghan J (1993) Recurrent squamous cell carcinoma of the vulva: a study of 73 cases. Gynecol Oncol 48:189–195

    Article  PubMed  CAS  Google Scholar 

  • Rouzier R, Haddad B, Plantier F, Dubois P, Pelisse M, Paniel BJ (2002) Local relapse in patients treated for squamous cell vulvar carcinoma: incidence and prognostic value. Obstet Gynecol 100:1159–1167

    Article  PubMed  Google Scholar 

  • Rouzier R, Haddad B, Atallah D, Dubois P, Paniel BJ (2005) Surgery for vulvar cancer. Clin Obstet Gynecol 48:869–878

    Article  PubMed  CAS  Google Scholar 

  • Sharma DN (2012) Radiation in vulvar cancer. Curr Opin Obstet Gynecol 24:24–30

    Article  PubMed  Google Scholar 

  • Viswanathan AN, Pinto AP, Schultz D, Berkowitz R, Crum CP (2013) Relationship of margin status and radiation dose to recurrence in post-operative vulvar carcinoma. Gynecol Oncol 130:545–549

    Article  PubMed  Google Scholar 

  • von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP (2007) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370:1453–1457

    Article  Google Scholar 

  • Woelber L, Choschzick M, Eulenburg C, Hager M, Jaenicke F, Gieseking F, Kock L, Ihnen M, Petersen C, Schwarz J, Mahner S (2011) Prognostic value of pathological resection margin distance in squamous cell cancer of the vulva. Ann Surg Oncol 18:3811–3818

    Article  PubMed  Google Scholar 

  • Woelber L, Trillsch F, Kock L, Grimm D, Petersen C, Choschzick M, Jaenicke F, Mahner S (2013) Management of patients with vulvar cancer: a perspective review according to tumour stage. Ther Adv Med Oncol 5:183–192

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Atanas Ignatov.

Ethics declarations

Conflict of interest

All authors declare that they have no conflict of interest.

Animal rights

This article does not contain any studies with animals performed by any of the authors.

Ethical standards

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Written informed consent was obtained from all patients before treatment. An additional individual consent for this analysis was not needed.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ignatov, T., Eggemann, H., Burger, E. et al. Adjuvant radiotherapy for vulvar cancer with close or positive surgical margins. J Cancer Res Clin Oncol 142, 489–495 (2016). https://doi.org/10.1007/s00432-015-2060-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-015-2060-9

Keywords

Navigation